Quest Pharmatech Inc logo

QPT - Quest Pharmatech Inc News Story

C$0.16 0.0  0.0%

Last Trade - 10/08/20

Sector
Healthcare
Size
Micro Cap
Market Cap £15.4m
Enterprise Value £15.3m
Revenue £n/a
Position in Universe 1182nd / 2675

BRIEF-OncoQuest Retains Services Of IQVIA To Manage Phase 3 Study In Frontline Ovarian Cancer

Fri 25th January, 2019 11:22pm
Jan 25 (Reuters) - IQVIA Holdings Inc  IQV.N :
    * QUEST PHARMATECH - UNIT RETAINED SERVICES OF IQVIA TO
MANAGE
UNIT'S PLANNED PHASE 3 CLINICAL STUDY IN FRONTLINE OVARIAN
CANCER WITH OREGOVOMAB

Source text for Eikon:  ID:nCNW0YyHQa 
Further company coverage:  IQV.N 

 ((Reuters.Briefs@thomsonreuters.com;;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.